Welcome to our dedicated page for Innovative Medtech SEC filings (Ticker: IMTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IMTH SEC filings page provides access to regulatory disclosures for the corporate entity historically known as Innovative MedTech, Inc. and later reported as AnTix Holdings, Inc. These filings document the company’s evolution from a health and wellness services provider with adult day care and healthcare digital wallet operations to a business that has also engaged in software and artificial intelligence transactions related to ticketing.
Through this page, readers can review current and historical reports filed with the U.S. Securities and Exchange Commission, including Form 8-K filings that describe material events. For example, one 8-K details a corporate name change from Innovative MedTech, Inc. to AnTix Holdings, Inc., noting that the company’s common stock continued to trade under the IMTH ticker symbol while it intended to seek a new symbol. Another 8-K explains an Asset Purchase Agreement and amendments involving assets of Grand Concierge LLC, doing business as Ticketbash, associated with retail and wholesale event ticket pricing and the development of software and artificial intelligence related to the ticket business. The Second Amendment described in that filing states that the company ultimately acquired a copy of and a non-exclusive license and rights to use Ticketbash’s complete source code and related materials.
On Stock Titan, IMTH filings are updated as they are made available through EDGAR. AI-powered summaries help explain the key points of lengthy documents, highlighting items such as material agreements, corporate name changes, and asset acquisitions or restructurings. Users can quickly identify how the company’s focus has shifted over time, from health and wellness operations and the RX Vitality acquisition to later software and AI ticketing assets under the AnTix Holdings identity. This page is a resource for investors and researchers seeking to understand the formal disclosures that shape IMTH’s corporate history.
AnTix Holdings, Inc. (IMTH) reports results for the year ended June 30, 2025, highlighting a major business shift and balance sheet changes. The company posted net income of $1,268,903, compared with a net loss of $7,938,897 the prior year, driven largely by a $3,366,943 gain on the disposition of its SarahCare adult day services subsidiaries and income from discontinued operations.
The core business generated no revenue from continuing operations in 2025, while operating expenses from continuing operations fell to $2,728,979 from $4,003,417, mainly due to lower stock-based compensation and consulting costs. Other income was helped by a $1,140,708 gain on extinguishment of debt, partially offset by a $440,800 impairment on deposits for acquisitions.
The company is exiting adult day services and repositioning as a technology-focused ticketing and media business built around Ticketbash’s artificial intelligence and dynamic pricing software, while maintaining a health and wellness presence through an exclusive Oral Thrush license. Despite reporting net income, AnTix has cumulative losses of $43,292,307, cash of $13,616, a working capital deficit of $1,280,533, and its auditors and management disclose substantial doubt about its ability to continue as a going concern.
Innovative MedTech, Inc. agreed to acquire assets from Grand Concierge LLC d/b/a Ticketbash through an Asset Purchase Agreement originally structured to issue equity and contingent cash/royalty payments but later amended twice. The initial deal would have issued 20,000,000 common shares plus 1,151,500 Series A preferred (convertible into 115,150,000 common) so the sellers would hold 60% of voting rights, and contemplated a $2,000,000 contingent cash payment, royalty tiers (2% up to $15,000,000, 4% between $15,000,000–$25,000,000, and 5% above $25,000,000), plus an additional $1,000,000 investment in development.
Amendments converted the structure twice and ultimately limited the acquisition to a copy and non-exclusive license to Ticketbash source and object code and related materials, with the Purchase Price reduced to the $469,500 already paid by the company. The parties treat the Purchase as closed on October 3, 2025.
AnTix Holdings, Inc., formerly known as Innovative MedTech, Inc., has officially changed its corporate name. On September 19, 2025, the company filed a Certificate of Amendment in Delaware to amend its Amended and Restated Certificate of Incorporation and adopt the new name AnTix Holdings, Inc.
The company’s common stock will continue to trade under the ticker symbol “IMTH” for now. The company states that it intends to file with FINRA to complete the name change process and to change its ticker symbol to a new symbol in the future. Existing stock certificates remain valid and do not need to be exchanged as a result of this name change.